Novo Gets €15 Billion of Orders for Akero Acquisition Bonds

Novo Nordisk A/S has pulled in more than €15 billion ($17.4 billion) of investor orders for its multi-tranche bond sale, more than triple the amount the Danish drugmaker is seeking for its planned purchase of US biotech Akero Therapeutics Inc.